Carsten Reinhardt
Overview
Explore the profile of Carsten Reinhardt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
2489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Cock W, Reinhardt C
Stud Hist Philos Sci
. 2024 Sep;
107:118-127.
PMID: 39243666
This article explores the emergence of molecular approaches in German genetic research during the 1958-1968 decade as a period of contingency and alternative possibilities. We introduce "Narratives of Contingency" as...
2.
Tsimberidou A, Guenther K, Andersson B, Mendrzyk R, Alpert A, Wagner C, et al.
Cancer Immunol Res
. 2023 May;
11(7):925-945.
PMID: 37172100
IMA101 is an actively personalized, multi-targeted adoptive cell therapy (ACT), whereby autologous T cells are directed against multiple novel defined peptide-HLA (pHLA) cancer targets. HLA-A*02:01-positive patients with relapsed/refractory solid tumors...
3.
Kim G, Fritsche J, Bunk S, Mahr A, Unverdorben F, Tosh K, et al.
Sci Transl Med
. 2022 Aug;
14(660):eabo6135.
PMID: 36044599
T cell receptor (TCR)-based immunotherapy has emerged as a promising therapeutic approach for the treatment of patients with solid cancers. Identifying peptide-human leukocyte antigen (pHLA) complexes highly presented on tumors...
4.
Loffler M, Gori S, Izzo F, Mayer-Mokler A, Ascierto P, Konigsrainer A, et al.
Clin Cancer Res
. 2022 Apr;
28(12):2555-2566.
PMID: 35421231
Purpose: Immunotherapy for hepatocellular carcinoma (HCC) shows considerable promise in improving clinical outcomes. HepaVac-101 represents a single-arm, first-in-human phase I/II multicenter cancer vaccine trial for HCC (NCT03203005). It combines multipeptide...
5.
Zheng L, Zywietz U, Birr T, Duderstadt M, Overmeyer L, Roth B, et al.
Microsyst Nanoeng
. 2021 Sep;
7:64.
PMID: 34567776
The advancement of micro- and nanostructuring techniques in optics is driven by the demand for continuous miniaturization and the high geometrical accuracy of photonic devices and integrated systems. Here, UV-LED...
6.
Zheng L, Zywietz U, Evlyukhin A, Roth B, Overmeyer L, Reinhardt C
Sensors (Basel)
. 2019 Oct;
19(21).
PMID: 31653086
Special integrated photonic surface structures composed of a dielectric semicircle ridge and a dielectric block placed on a metal substrate are proposed for the investigation of surface plasmon polariton (SPP)...
7.
Klick A, Grossmann M, Beewen M, Bittorf P, Fiutowski J, Leissner T, et al.
Rev Sci Instrum
. 2019 Jun;
90(5):053704.
PMID: 31153234
We present an advanced experimental setup for time-resolved photoemission electron microscopy (PEEM) with sub-20 fs resolution, which allows for normal incidence and highly local sample excitation with ultrashort laser pulses....
8.
Zheng L, Kurselis K, El-Tamer A, Hinze U, Reinhardt C, Overmeyer L, et al.
Nanoscale Res Lett
. 2019 Apr;
14(1):134.
PMID: 30997578
In this paper, approaches for the realization of high-resolution periodic structures with gap sizes at sub-100 nm scale by two-photon polymerization (2PP) are presented. The impact of laser intensity on...
9.
Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanovic S, Gouttefangeas C, et al.
Nature
. 2019 Feb;
566(7745):E13.
PMID: 30733620
The additional author support information was erroneously omitted from the Supplementary Information. This has been corrected online.
10.
Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanovic S, Gouttefangeas C, et al.
Nature
. 2018 Dec;
565(7738):240-245.
PMID: 30568303
Patients with glioblastoma currently do not sufficiently benefit from recent breakthroughs in cancer treatment that use checkpoint inhibitors. For treatments using checkpoint inhibitors to be successful, a high mutational load...